UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model

International journal of oral and maxillofacial surgery, 2009-04, Vol.38 (4), p.350-355

2009

Volltextzugriff (PDF)

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

Arteriosclerosis, thrombosis, and vascular biology, 2002-09, Vol.22 (9), p.1500

2002

Volltextzugriff (PDF)

3B.3 Prevention and treatment of cancer associated thrombosis

Thrombosis research, 2007, Vol.119, p.S36-S36

Kakkar, A.K

2007

Volltextzugriff (PDF)

The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry

Journal of thrombosis and haemostasis, 2004-11, Vol.2 (11), p.1892-1898

2004

Volltextzugriff (PDF)

Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2192-2198

2003

Volltextzugriff (PDF)

Antithrombotic therapy and survival in cancer patients

Best practice & research. Clinical haematology, 2009-03, Vol.22 (1), p.147-151

Kakkar, A.K

2009

Volltextzugriff (PDF)

Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism

Journal of vascular surgery, 2010, Vol.51 (2), p.522-522

2010

Volltextzugriff (PDF)

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.56-70

2013

Volltextzugriff (PDF)

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1028-1035

2015

Volltextzugriff (PDF)

3001 POSTER DISCUSSION Ultra-low-molecular-weight Heparin (ULMWH) Semuloparin for Prevention of Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: Consistent Beneficial Effect Across Cancer Stage and Location Subgroups

European journal of cancer (1990), 2011, Vol.47, p.S222-S222

2011

Volltextzugriff (PDF)

International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.71-80

2013

Volltextzugriff (PDF)

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Thrombosis research, 2020-01, Vol.185, p.13-19

2020

Volltextzugriff (PDF)

Abstract related to PL-22 Guidelines for antithrombotics in cancer patients

Thrombosis research, 2012-04, Vol.129, p.S194-S194

2012

Volltextzugriff (PDF)

Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate?

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

A to Z of Venous Thromboembolism: A Thesaurus

2, 2021

Volltextzugriff (PDF)

Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

The role of radiotherapy in treating small early invasive breast cancer

European journal of surgical oncology, 2008-04, Vol.34 (4), p.369-376

2008

Volltextzugriff (PDF)

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(65)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(27)
Hematology
(14)
Female
(12)
Cardiovascular System & Cardiology
(10)
Peripheral Vascular Disease
(10)
Medical Sciences
(9)
Middle Aged
(9)
Neoplasms - Complications
(9)
Biological And Medical Sciences
(8)
Male
(8)
Adult
(7)
Risk Factors
(7)
Surgery
(7)
Treatment Outcome
(7)
Venous Thromboembolism
(6)
Cancer
(5)
Hematology, Oncology And Palliative Medicine
(5)
Oncology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model

Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients

3B.3 Prevention and treatment of cancer associated thrombosis

The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry

Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416

Antithrombotic therapy and survival in cancer patients

Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

3001 POSTER DISCUSSION Ultra-low-molecular-weight Heparin (ULMWH) Semuloparin for Prevention of Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: Consistent Beneficial Effect Across Cancer Stage and Location Subgroups

International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Abstract related to PL-22 Guidelines for antithrombotics in cancer patients

Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate?

Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry

A to Z of Venous Thromboembolism: A Thesaurus

Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry

Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry

Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry

Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria

The role of radiotherapy in treating small early invasive breast cancer

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF

Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry

Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry

The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry

Suchergebnisse filtern